Plants are a significant source of crops for human consumption, raw materials for animal feed, plant-based chemicals for industrial use, and renewable energy sources such as biofuels. Existing rates of crop yield increases will not be able to suffice the planet’s growing need for agriculture produces with the exponential growth of the human population. CRISPR Cas9 tools play a diverse role in agriculture by enabling the industry in editing crops. The CRISPR Cas9 market by agriculture and plant breeding has tremendous potential to reduce global food shortage. Traditional breeding methods require tremendous efforts to adapt advantageous variants of relevant genes to the best varieties and are still time-consuming due to extensive back-crossing necessary for specific traits integration. Transgenic technology can knock over the incompatibility issues between plant species by conjoining foreign genes to target plant genomes.
As the research and development investment in the technology is growing by leaps and bounds. So, the technology’s potential has been explored in newer areas of agriculture and plant breeding products. CRISPR-Cas9 is becoming a pre-requisite tool in genome editing market and the programmable capacity of the Cas9 enzyme is now transforming varied fields one of them is agriculture.
CRISPR-Cas9 tools will play a multifarious role in agriculture by enabling the industry in editing crops to make them more nutritious, enhanced taste, disease resistant, and less susceptible to drought. Agriculture and plant breeding application segment is restricted in growth by several potential regulatory requirements and ethical apprehensions. With the USFDA announcement of CRISPR-Cas9 edited crops being treated as non-GMOs, in 2025 the application segment is expected to grow by four times of its market size in 2017 to $609 million in 2025. CRISPR-Cas9 benefits realization is still at an embryonic stage.
Drought environments are a huge crop killer reducing 10 per cent of the crop yield over the past 50 years, and the climatic shifts are going to worsen the scenario. In 2016, DowDuPont started growing CRISPR-Cas9 edited waxy corn used to thicken food products and make adhesives and wheat. Genome editing has been carried out to develop drought-resistant corn and introduce hybrid wheat. As drought becomes a progressively significant problem, CRISPR-Cas9 technology represents game-changers in the struggle against the global food shortage and crises.
The advent of CRISPR-Cas9 has provided agri-biotech companies in opportunities to introduce significant alterations in plant genome for gene silencing or enhancement of gene expression. CRISPR-Cas9 technology is already having a profound impact on matters relating to the global food crisis by addressing the issue in three ways: decreasing flowering time, preventing disease, and increasing yield in drought conditions.
CRISPR -Cas9 has contributed significantly in technological advancement in the field of agriculture biotechnology to yield gene edited crops and not genetically engineered crops. Researchers are experimenting with CRISPR-Cas9 tools to obtain specific traits such as transgene-free plants, increasing viral disease resistance, precision breeding, enhancing yield performance, bio fortification, and improving tolerance to abiotic and biotic stress. DuPont, Monsanto, and BASF have already licensed the CRISPR tool for use in new crop and seed development are investing heavily both monetarily and experience wise in the CRISPR-Cas9 agriculture and plant breeding market to drive the market growth. Innovative agricultural business platforms.
CRISPR-based genome editing potentials are emerging fast. Cloud biology combines artificial intelligence, DNA data, machine learning and analytics to reduce the time needed to breed new crops. Cost-effectiveness of CRISPR-Cas9 tools accompanied by efficient gene editing and easy of engineering has provided researchers with a new toolbox for enhanced and improved crop production.
To know more about Crispr Cas9 in agriculture and plant breeding visit – Crispr Cas9 Market Report.